# EDGAR Filing Document

**Accession Number:** 0001845257
**File Stem:** 0001193125-26-071548
**Filing Date:** 2026-2
**Character Count:** 16580
**Document Hash:** f1485f0f8df78b67de3bed39ab7b0b57
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-071548.hdr.sgml**: 20260225

**ACCESSION NUMBER**: 0001193125-26-071548

**CONFORMED SUBMISSION TYPE**: S-8

**PUBLIC DOCUMENT COUNT**: 15

**FILED AS OF DATE**: 20260225

**DATE AS OF CHANGE**: 20260225

**EFFECTIVENESS DATE**: 20260225

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** LifeStance Health Group, Inc.
- **CENTRAL INDEX KEY:** 0001845257
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-HEALTH SERVICES [8000]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** S-8
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-293729
- **FILM NUMBER:** 26678591

**BUSINESS ADDRESS:**
- **STREET 1:** 4800 N. SCOTTSDALE ROAD
- **STREET 2:** SUITE 2500
- **CITY:** SCOTTSDALE
- **STATE:** AZ
- **ZIP:** 85251
- **BUSINESS PHONE:** 602-767-2100

**MAIL ADDRESS:**
- **STREET 1:** 4800 N. SCOTTSDALE ROAD
- **STREET 2:** SUITE 2500
- **CITY:** SCOTTSDALE
- **STATE:** AZ
- **ZIP:** 85251

**As filed with the Securities and Exchange Commission on February 25, 2026** 

**Registration No. 333-** 

------

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**WASHINGTON, D.C. 20549** 

------

**FORM S-8** 

**REGISTRATION STATEMENT** 

***under*** 

***the SECURITIES ACT OF 1933*** 

------

**LifeStance Health Group, Inc.**

**(Exact Name of Registrant as Specified in Its Charter)** 

------

---

| | |
|:---|:---|
| **Delaware** | **86-1832801** |
| **(State or Other Jurisdiction of**<br>**Incorporation or Organization)** | **(I.R.S. Employer**<br>**Identification No.)** |

---

**4800 N. Scottsdale Road, Suite 2500** 

**Scottsdale, AZ 85251** 

**(602) 767-2100** 

**(Address of Principal Executive Offices) (Zip Code)** 

**LifeStance Health Group, Inc. 2021 Equity Incentive Plan** 

**LifeStance Health Group, Inc. 2021 Employee Stock Purchase Plan** 

**(Full Title of the Plans)** 

**David Bourdon** 

**Chief Executive Officer** 

**LifeStance Health Group, Inc.** 

**4800 N. Scottsdale Road, Suite 2500** 

**Scottsdale, AZ 85251** 

**(602) 767-2100** 

**(Name, Address and Telephone Number of Agent for Service)** 

---

| | |
|:---|:---|
| ***with copies to:*** | ***with copies to:*** |
| **Thomas Fraser**<br>**Ropes & Gray LLP**<br>**Prudential Tower**<br>**800 Boylston Street**<br>**Boston, MA 02199-3600**<br>**(617) 951-7000** | **Ryan Pardo**<br>**Chief Legal Officer and Secretary**<br>**LifeStance Health Group, Inc.**<br>**10655 NE 4th St #701**<br>**Bellevue, WA 98004**<br>**(425) 279-8500** |

---

------

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☒ | Accelerated filer | ☐ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
|  |  | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act ☐

------

**EXPLANATORY NOTE** 

This Registration Statement on Form S-8 registers additional shares of the Registrant's common stock, par value $0.01 per share (the "Common Stock"), under the LifeStance Health Group, Inc. 2021 Equity Incentive Plan (the "2021 Plan") and the LifeStance Health Group, Inc. 2021 Employee Stock Purchase Plan (the "ESPP").

The number of shares of Common Stock reserved and available for issuance under the 2021 Plan is subject to an automatic annual increase on January 1st of each year through and including 2031 by the lesser of (i) five percent (5%) of the number of shares of Common Stock outstanding as of the close of business on the immediately preceding December 31st and (ii) the number of shares of Common Stock determined by the Board of Directors of the Registrant (the "Board") on or prior to such date for such year. On January 1, 2026, the number of shares of Common Stock reserved and available for issuance under the 2021 Plan increased by 19,415,878 shares.

The number of shares of Common Stock reserved and available for issuance under the ESPP is subject to an automatic annual increase on January 1st of each year through and including 2031 by the lesser of (i) one percent (1%) of the number of shares of Common Stock outstanding as of the close of business on the immediately preceding December 31st and (ii) the number of shares of Common Stock determined by the Board on or prior to such date for such year, up to a maximum of 42,500,000 shares in the aggregate. On January 1, 2026, the number of shares of Common Stock reserved and available for issuance under the ESPP increased by 3,883,176 shares.

This Registration Statement on Form S-8 registers these additional 23,299,054 shares of Common Stock. The additional shares are of the same class as other securities relating to the plans for which the Registrant's registration statements filed on Form S-8 on June 14, 2021 (Registration No. 333-257086), Form S-8 on March 17, 2022 (Registration No. 333-263653), Form S-8 on March 9, 2023 (Registration No. 333-270403), Form S-8 on February 28, 2024 (Registration No. 333-277473) and Form S-8 on February 27, 2025 (Registration No. 333-285352) are effective. The information contained in the Registrant's registration statements on Form S-8 (Registration Nos. 333-257086, 333-263653, 333-270403, 333-277473 and 333-285352) is hereby incorporated by reference pursuant to General Instruction E.

------

**PART II** 

**INFORMATION REQUIRED IN THE REGISTRATION STATEMENT** 

---

| | |
|:---|:---|
| **Item 8.** | **Exhibits.**  |

---

---

| | |
|:---|:---|
| **Exhibit**<br>**Number** | **Description** |
| 4.1 | [<u>Amended and Restated Certificate of Incorporation of LifeStance Health Group, Inc. (previously filed as Exhibit 3.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on June 15, 2021 and incorporated herein by reference)</u>](https://www.sec.gov/Archives/edgar/data/1845257/000119312521191198/d176095dex31.htm) |
| 4.2 | [<u>Second Amended and Restated Bylaws of LifeStance Health Group, Inc. (previously filed as Exhibit 3.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on March 8, 2023 and incorporated herein by reference)</u>](https://www.sec.gov/Archives/edgar/data/1845257/000095017023006541/lfst-ex3_1.htm) |
| 4.3 | [<u>Form of Common Stock Certificate (previously filed as Exhibit 4.1 to the Registration Statement on Form S-1 (File No. 333-256202) filed on June 1, 2021 and incorporated herein by reference)</u>](https://www.sec.gov/Archives/edgar/data/1845257/000119312521177685/d112007dex41.htm) |
| 4.4 | [<u>LifeStance Health Group, Inc. 2021 Equity Incentive Plan (previously filed as Exhibit 10.4 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on June 15, 2021 and incorporated herein by reference)</u>](https://www.sec.gov/Archives/edgar/data/1845257/000119312521191198/d176095dex104.htm) |
| 4.5 | [<u>LifeStance Health Group, Inc. 2021 Employee Stock Purchase Plan (previously filed as Exhibit 10.5 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on June 15, 2021 and incorporated herein by reference)</u>](https://www.sec.gov/Archives/edgar/data/1845257/000119312521191198/d176095dex105.htm) |
| 5.1 | [<u>Opinion of Ropes & Gray LLP</u>](lfst-ex5_1.htm) |
| 23.1 | [<u>Consent of Independent Registered Public Accounting Firm, PricewaterhouseCoopers LLP</u>](lfst-ex23_1.htm) |
| 23.2 | [<u>Consent of Ropes & Gray LLP (included in Exhibit 5.1)</u>](lfst-ex5_1.htm) |
| 24.1 | [<u>Power of Attorney (included on the signature page of the Registration Statement)</u>](#poa) |
| 107 | [<u>Filing Fee Table</u>](lfst_exfilingfees.htm) |

---

------

**SIGNATURES** 

Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Scottsdale, State of Arizona, on February 25, 2026.

---

| | |
|:---|:---|
| LifeStance Health Group, Inc. | LifeStance Health Group, Inc. |
| By: | /s/ David Bourdon |
| Name: | **David Bourdon** |
| Title:  | **Chief Executive Officer** |

---

\* \* \*

**SIGNATURES & POWER OF ATTORNEY** 

Each person whose signature appears below constitutes and appoints David Bourdon, Ryan McGroarty, and Ryan Pardo, and each of them singly, his true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution in each of them singly, for him and in his name, place and stead, and in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement on Form S-8 of LifeStance Health Group, Inc., and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting to the attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite or necessary to be done in or about the premises, as full to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that the attorneys-in-fact and agents or any of each of them or their substitutes may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

---

| | | |
|:---|:---|:---|
| **Signature** | **Title** | **Date** |
| /s/ David Bourdon | Chief Executive Officer and Director | February 25, 2026 |
| **David Bourdon** | (Principal Executive Officer) |  |
| /s/ Ryan McGroarty | Chief Financial Officer and Treasurer | February 25, 2026 |
| **Ryan McGroarty** | (Principal Financial Officer and Principal Accounting Officer) |  |
| /s/ Kenneth Burdick | Executive Chairperson of the Board of Directors | February 25, 2026 |
| **Kenneth Burdick** |  |  |
| /s/ Robert Bessler | Director | February 25, 2026 |
| **Robert Bessler** |  |  |
| /s/ Darren Black | Director | February 25, 2026 |
| **Darren Black** |  |  |
| /s/ Teresa DeLuca | Director | February 25, 2026 |
| **Teresa DeLuca** |  |  |
| /s/ Eric Palmer | Director | February 25, 2026 |
| **Eric Palmer** |  |  |
| /s/ Sarah Personette | Director | February 25, 2026 |
| **Sarah Personette** |  |  |
| /s/ Jeffrey Rhodes | Director | February 25, 2026 |
| **Jeffrey Rhodes** |  |  |
| /s/ Eric Shuey | Director | February 25, 2026 |
| **Eric Shuey** |  |  |
| /s/ Katherine Wood | Director | February 25, 2026 |
| **Katherine Wood** |  |  |

---

------

## Exhibit 5.1

**Exhibit 5.1** 

---

| | |
|:---|:---|
| ![img137972501_0.jpg](img137972501_0.jpg) | ROPES & GRAY LLP<br>PRUDENTIAL TOWER<br>800 BOYLSTON STREET<br>BOSTON, MA 02199-3600<br>WWW.ROPESGRAY.COM |

---

February 25, 2026

LifeStance Health Group, Inc.

4800 N. Scottsdale Road, Suite 2500

Scottsdale, AZ 85251

Re: <u>Registration Statement on Form S-8</u>

Ladies and Gentlemen:

This opinion is furnished to you in connection with the registration statement on Form S-8 (the "<u>Registration Statement</u>"), filed with the Securities and Exchange Commission (the "<u>Commission</u>") under the Securities Act of 1933, as amended (the "<u>Securities Act</u>"), for the registration of an aggregate of 23,299,054 shares (the "<u>Shares</u>") of common stock, $0.01 par value ("<u>Common Stock</u>") of LifeStance Health Group, Inc., a Delaware corporation (the "<u>Company</u>"), including (i) 19,415,878 shares of Common Stock issuable under the LifeStance Health Group, Inc. 2021 Equity Incentive Plan (the "<u>2021 Plan</u>") and (ii) 3,883,176 shares of Common Stock issuable under the LifeStance Health Group, Inc. 2021 Employee Stock Purchase Plan (the "<u>2021 ESPP</u>" and, together with the 2021 Plan, the "<u>Plans</u>").

We are familiar with the actions taken by the Company in connection with the adoption of the Plans. For purposes of our opinion, we have examined and relied upon such documents, records, certificates and other instruments as we have deemed necessary.

The opinions expressed below are limited to the Delaware General Corporation Law.

Based on the foregoing, we are of the opinion that the Shares have been duly authorized and, when the Shares have been issued and sold in accordance with the Plans, the Shares will be validly issued, fully paid and nonassessable.

We hereby consent to the filing of this opinion as an exhibit to the Registration Statement. In giving this consent we do not thereby admit that we are included in the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission promulgated thereunder.

---

| |
|:---|
| Very truly yours, |
| /s/ Ropes & Gray LLP |
| Ropes & Gray LLP |

---

------

## Exhibit 23.1

**Exhibit 23.1** 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in this Registration Statement on Form S-8 of LifeStance Health Group, Inc. of our report dated February 25, 2026 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in LifeStance Health Group, Inc.'s Annual Report on Form 10-K for the year ended December 31, 2025.

/s/ PricewaterhouseCoopers LLP<br>Seattle, Washington<br>February 25, 2026

------

## Ex-Filing

?xml version='1.0' encoding='ASCII'? EX-FILING FEES

**Exhibit 107** 

**Calculation of** Filing Fee **Tables**

Form S-8

(Form Type)

LifeStance Health Group, Inc.

(Exact Name of Registrant as Specified in its Charter)

<u>Table 1: Newly Registered Securities</u>

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| Security **Type** | **Security Class Title** | **Fee Calculation Rule** | **Amount Registered (1)** | **Proposed Maximum Offering Price Per Unit** | **Maximum Aggregate Offering Price** | **Fee Rate** | **Amount of Registration Fee** |
| Equity | LifeStance Health Group, Inc. 2021 Equity Incentive Plan Common Stock, $0.01 par value | Other - 457(c) and 457(h) | 19,415,878 shares (2) | $7.07 (3) | $137270257.46 | $138.10 | $18957.02 |
| Equity | LifeStance Health Group, Inc. 2021 Employee Stock Purchase Plan Common Stock, $0.01 par value | Other - 457(c) and 457(h) | 3,883,176 shares (4) | $7.07 (3) | $27454054.32 | $138.10 | $3791.40 |
| **Total Offering Amounts** | **Total Offering Amounts** | **Total Offering Amounts** | **Total Offering Amounts** | **Total Offering Amounts** | $164724311.78 |  | $22748.42 |
| **Total Fee Offsets** | **Total Fee Offsets** | **Total Fee Offsets** | **Total Fee Offsets** | **Total Fee Offsets** |  |  | N/A |
| **Net Fee Due** | **Net Fee Due** | **Net Fee Due** | **Net Fee Due** | **Net Fee Due** |  |  | $22748.42 |

---

(1)Pursuant to Rule 416(a) of the Securities Act of 1933, as amended, this Registration Statement also covers an indeterminable number of additional shares of the registrant's common stock that may become issuable pursuant to terms designed to prevent dilution resulting from share splits, share dividends or similar events.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)Represents an increase to the number of shares available for issuance under the LifeStance Health Group, Inc. 2021 Equity Incentive Plan, effective as of January 1, 2026.

(3)Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(h) based on the average of the high and low prices of the registrant's Common Stock as reported on the Nasdaq Global Select Market on February 19, 2026 to be $6.94 and $7.20, respectively.

(4)Represents an increase to the number of shares available for issuance under the LifeStance Health Group, Inc. 2021 Employee Stock Purchase Plan, effective as of January 1, 2026.

------